PL328925A1 - Method of treating bipolar disorders - Google Patents

Method of treating bipolar disorders

Info

Publication number
PL328925A1
PL328925A1 PL96328925A PL32892596A PL328925A1 PL 328925 A1 PL328925 A1 PL 328925A1 PL 96328925 A PL96328925 A PL 96328925A PL 32892596 A PL32892596 A PL 32892596A PL 328925 A1 PL328925 A1 PL 328925A1
Authority
PL
Poland
Prior art keywords
bipolar disorders
treating bipolar
treating
disorders
bipolar
Prior art date
Application number
PL96328925A
Other languages
English (en)
Inventor
Charles Merritt Beasley Jr
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL328925A1 publication Critical patent/PL328925A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
PL96328925A 1996-03-11 1996-12-04 Method of treating bipolar disorders PL328925A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
PCT/US1996/019575 WO1997033577A1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorder

Publications (1)

Publication Number Publication Date
PL328925A1 true PL328925A1 (en) 1999-03-01

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96328925A PL328925A1 (en) 1996-03-11 1996-12-04 Method of treating bipolar disorders

Country Status (15)

Country Link
EP (1) EP0889725A4 (cs)
JP (1) JP2000506859A (cs)
KR (1) KR19990087713A (cs)
CN (1) CN1213966A (cs)
AU (1) AU734011B2 (cs)
BR (1) BR9612548A (cs)
CZ (1) CZ290298A3 (cs)
EA (1) EA000758B1 (cs)
HU (1) HUP9903679A3 (cs)
IL (1) IL126162A0 (cs)
NO (1) NO984189D0 (cs)
NZ (1) NZ326031A (cs)
PL (1) PL328925A1 (cs)
TR (1) TR199801797T2 (cs)
WO (1) WO1997033577A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101901A3 (en) * 1998-05-22 2002-06-28 Lilly Co Eli Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
BR9911068A (pt) * 1998-05-29 2001-02-06 Lilly Co Eli Terapia combinada para tratamento de distúrbios bipolares
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
JP2002530340A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． オランザピン−ｎ−オキサイドを含む医薬組成物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
CZ290298A3 (cs) 1999-10-13
TR199801797T2 (xx) 1998-12-21
EA000758B1 (ru) 2000-04-24
HUP9903679A2 (hu) 2000-04-28
NO984189L (no) 1998-09-11
EA199800819A1 (ru) 1999-02-25
JP2000506859A (ja) 2000-06-06
AU734011B2 (en) 2001-05-31
AU1330797A (en) 1997-10-01
NO984189D0 (no) 1998-09-11
HUP9903679A3 (en) 2001-10-29
EP0889725A1 (en) 1999-01-13
IL126162A0 (en) 1999-05-09
WO1997033577A1 (en) 1997-09-18
NZ326031A (en) 2001-05-25
EP0889725A4 (en) 2000-01-19
KR19990087713A (ko) 1999-12-27
BR9612548A (pt) 1999-07-20
CN1213966A (zh) 1999-04-14

Similar Documents

Publication Publication Date Title
EP0946485A4 (en) METHOD FOR TREATING DERMATOLOGICAL DISEASES
GB9617780D0 (en) Method of treatment
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) PAIN TREATMENT PROCESS
EP0933803A4 (en) PLASMA TREATMENT METHOD
GB9712866D0 (en) Novel method of treatment
GB9605828D0 (en) Treatment method
IL126064A0 (en) Method for treating pain
AU2251897A (en) Method of treating liver disorders
AU5198898A (en) Method for treatment of glutamate related disorders
GB9707693D0 (en) Novel method of treatment
PL328925A1 (en) Method of treating bipolar disorders
IL127182A0 (en) Method of improving skin condition
SG64990A1 (en) Method of treating polyolefin
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
AU1282099A (en) Method for treatment of disorders of attention
GB2294880B (en) Method of treating turf
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
EP0912178A4 (en) METHOD FOR TREATING THE HIGH PRESSURE
GB9600888D0 (en) Method of treatment
GB9414652D0 (en) Method of treatment
GB9602404D0 (en) Methods of treatment
GB9606619D0 (en) Method for treating bipolar disorder